PMID- 35941897
OWN - NLM
STAT- MEDLINE
DCOM- 20220810
LR  - 20230410
IS  - 1748-6718 (Electronic)
IS  - 1748-670X (Print)
IS  - 1748-670X (Linking)
VI  - 2022
DP  - 2022
TI  - Application Value of Evidence-Based Care in Patients with Lung Cancer 
      Chemotherapy.
PG  - 5747712
LID - 10.1155/2022/5747712 [doi]
LID - 5747712
AB  - OBJECTIVE: The present research project is aimed at elucidating the application 
      value of evidence-based care (EBC) in patients with lung cancer (LC) 
      chemotherapy. METHODS: Ninety-four advanced LC patients visited between March 
      2019 and February 2021 were retrospectively selected. Based on the type of care, 
      44 cases who used routine nursing were set as the control group (CG), and 50 
      patients who received EBC were included in the research group (RG). The pain 
      degree, adverse mood, and individual fatigue of patients were assessed, using the 
      Visual Analogue Scale (VAS), Self-Rating Anxiety/Depression Scale (SAS/SDS), and 
      Cancer Fatigue Scale (CFS), respectively. Besides, patients were assessed for 
      treatment compliance, self-efficacy, and life quality using the treatment 
      compliance questionnaire, General Self-Efficacy Scale (GSES), and Quality of Life 
      Questionnaire Core 30 (QLQ-C30), respectively. RESULTS: The VAS, SAS, and SDS 
      scores were lower in RG versus CG after nursing intervention. RG scored lower in 
      the dimensions of physical, affective, and cognitive fatigue in terms of 
      individual fatigue assessed by the CFS and higher in various domains of the 
      QLQ-C30 score after nursing intervention. Besides, higher treatment compliance 
      and self-efficacy were determined in RG as compared to CG. CONCLUSIONS: In 
      addition to improving the treatment compliance, self-efficacy, and life quality 
      of patients with LC chemotherapy, EBC can effectively alleviate their pain, 
      adverse psychological mood, and individual fatigue, which deserves to be promoted 
      in clinical application.
CI  - Copyright (c) 2022 Ying Chen et al.
FAU - Chen, Ying
AU  - Chen Y
AD  - Tumor Building, Affiliated Hospital of Jiangnan University, Wuxi City, 214061 
      Jiangsu Province, China.
FAU - Xu, Hong
AU  - Xu H
AD  - Tumor Building, Affiliated Hospital of Jiangnan University, Wuxi City, 214061 
      Jiangsu Province, China.
FAU - Cheng, Yun
AU  - Cheng Y
AD  - Tumor Building, Affiliated Hospital of Jiangnan University, Wuxi City, 214061 
      Jiangsu Province, China.
FAU - Qian, Yuan
AU  - Qian Y
AUID- ORCID: 0000-0001-9281-0286
AD  - Tumor Building, Nursing Department, Affiliated Hospital of Jiangnan University, 
      Wuxi City, 214061 Jiangsu Province, China.
LA  - eng
PT  - Journal Article
DEP - 20220730
PL  - United States
TA  - Comput Math Methods Med
JT  - Computational and mathematical methods in medicine
JID - 101277751
SB  - IM
MH  - Evidence-Based Medicine
MH  - Humans
MH  - *Lung Neoplasms/drug therapy
MH  - Pain
MH  - Quality of Life/psychology
MH  - Retrospective Studies
PMC - PMC9356818
COIS- The authors declare no competing interests.
EDAT- 2022/08/10 06:00
MHDA- 2022/08/11 06:00
PMCR- 2022/07/30
CRDT- 2022/08/09 01:55
PHST- 2022/06/08 00:00 [received]
PHST- 2022/07/06 00:00 [revised]
PHST- 2022/07/11 00:00 [accepted]
PHST- 2022/08/09 01:55 [entrez]
PHST- 2022/08/10 06:00 [pubmed]
PHST- 2022/08/11 06:00 [medline]
PHST- 2022/07/30 00:00 [pmc-release]
AID - 10.1155/2022/5747712 [doi]
PST - epublish
SO  - Comput Math Methods Med. 2022 Jul 30;2022:5747712. doi: 10.1155/2022/5747712. 
      eCollection 2022.